Related references
Note: Only part of the references are listed.Influenza vaccination in immunocompromised populations: Strategies to improve immunogenicity
Freddy Caldera et al.
VACCINE (2021)
Interferon-λ Enhances the Differentiation of Naive B Cells into Plasmablasts via the mTORC1 Pathway
Mohammedyaseen Syedbasha et al.
CELL REPORTS (2020)
Type I and type III interferons differ in their adjuvant activities for influenza vaccines
Liang Ye et al.
JOURNAL OF VIROLOGY (2019)
Influenza vaccination in the elderly
Jan Smetana et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Serum IgM levels independently predict immune response to influenza vaccine in long-term survivors vaccinated at >1 year after undergoing allogeneic hematopoietic stem cell transplantation
Yusuke Fukatsu et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2017)
The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy
Craig Kollman et al.
BLOOD (2016)
Sparse data bias: a problem hiding in plain sight
Sander Greenland et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Impact of host genetic polymorphisms on vaccine induced antibody response
Janina E. Linnik et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Sparse data bias: a problem hiding in plain sight
Sander Greenland et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Sex differences in immune responses
Sabra L. Klein et al.
NATURE REVIEWS IMMUNOLOGY (2016)
TheVGAMPackage for Categorical Data Analysis
Thomas W. Yee
Journal of Statistical Software (2015)
Immunomodulatory Function of Interleukin 28B During Primary Infection With Cytomegalovirus
Adrian Egli et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination
David Furman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Comparable humoral response after two doses of adjuvanted influenza A/H1N1pdm2009 vaccine or natural infection in allogeneic stem cell transplant recipients
Nathalie Dhedin et al.
VACCINE (2014)
IL-28B is a Key Regulator of B- and T-Cell Vaccine Responses against Influenza
Adrian Egli et al.
PLOS PATHOGENS (2014)
A Randomized Trial of One versus Two Doses of Influenza Vaccine after Allogeneic Transplantation
Nicole A. Karras et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
The effect of rituximab on vaccine responses in patients with immune thrombocytopenia
Ishac Nazi et al.
BLOOD (2013)
IL28RA polymorphism is associated with early hepatitis C virus (HCV) treatment failure in human immunodeficiency virus-/HCV-coinfected patients
M. A. Jimenez-Sousa et al.
JOURNAL OF VIRAL HEPATITIS (2013)
Vaccination against pandemic H1N1 (2009) in patients after allogeneic hematopoietic stem cell transplantation: a retrospective analysis
D. Roll et al.
INFECTION (2012)
Influenza Vaccination for Immunocompromised Patients: Systematic Review and Meta-analysis by Etiology
Charles R. Beck et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Multigenic control of measles vaccine immunity mediated by polymorphisms in measles receptor, innate pathway, and cytokine genes
Richard B. Kennedy et al.
VACCINE (2012)
Seroprotective Titers against 2009 H1N1 Influenza A Virus after Vaccination in Allogeneic Hematopoietic Stem Cell Transplantation Recipients
Nicolas C. Issa et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Enhanced Immune Response after a Second Dose of an AS03-Adjuvanted H1N1 Influenza A Vaccine in Patients after Hematopoietic Stem Cell Transplantation
Saskia Gueller et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host
Hugues de Lavallade et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients
Bilal Mohty et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Associations between single nucleotide polymorphisms and haplotypes in cytokine and cytokine receptor genes and immunity to measles vaccination
Iana H. Haralambieva et al.
VACCINE (2011)
The humoral immune response of hematopoietic stem cell transplantation recipients to AS03-adjuvanted A/California/7/2009 (H1N1)v-like virus vaccine during the 2009 pandemic
Dan Engelhard et al.
VACCINE (2011)
Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses
Ken M. Kunisaki et al.
LANCET INFECTIOUS DISEASES (2009)
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Dongliang Ge et al.
NATURE (2009)
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
David L. Thomas et al.
NATURE (2009)
IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
Vijayaprakash Suppiah et al.
NATURE GENETICS (2009)
Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
Yasuhito Tanaka et al.
NATURE GENETICS (2009)
Influenza vaccination in hematopoietic SCT recipients
P. Ljungman et al.
BONE MARROW TRANSPLANTATION (2008)
Evaluation of immune responses to seasonal influenza vaccination in healthy volunteers and in patients after stem cell transplantation
Gayane Avetisyan et al.
TRANSPLANTATION (2008)
Maximizing power in seroepidemiological studies through the use of the proportional odds model
Ana W. Capuano et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2007)
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report
AH Filipovich et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
The benefit of influenza vaccination after bone marrow transplantation
CM Machado et al.
BONE MARROW TRANSPLANTATION (2005)
Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection
AC Allison et al.
TRANSPLANTATION (2005)
Influenza infections after hematopoietic stem cell transplantation: Risk factors, mortality, and the effect of antiviral therapy
WG Nichols et al.
CLINICAL INFECTIOUS DISEASES (2004)
Granulocyte-macrophage colony-stimulating factor as immunomodulating factor together with influenza vaccination in stem cell transplant patients
K Pauksen et al.
CLINICAL INFECTIOUS DISEASES (2000)
Share Paper
